Phosphatidylethanol Is Cost-effective to Accurately Detect Periodic Alcohol Use in Patients With Alcohol-associated Liver Disease
Clinical Gastroenterology and Hepatology · 2026-02 · 24 (2) · 569-571
DOI: 10.1016/j.cgh.2025.07.022 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Gastroenterology and Hepatology, 2026-02. Verfasst von Stephen E Congly und 5 weiteren Autor:innen. Beteiligte Einrichtung: Divisions of Gastroenterology and Hepatology and Transplant Medicine, Department of Medicine, Cumming School of Medicine, University of Calgary, Calg…. Die Arbeit nennt 5 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Divisions of Gastroenterology and Hepatology and Transplant Medicine, Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada; Arnie Charbonneau Cancer Institute, O'Brien Inst…
- Division of Gastroenterology and Liver Diseases, University of Southern California, Los Angeles, California.
- Division of Liver Diseases, Recanati/Miller Transplantation Institute, Icahn School of Medicine at Mount Sinai, New York, New York.
- Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine and Science, Rochester, Minnesota.
- Departamento de Gastroenterología, Escuela De Medicina, Pontificia Universidad Católica De Chile, Santiago, Chile; MASLD Research Center, Division of Gastroenterology and Hepatology, University of California San Diego,…
- Departamento de Gastroenterología, Escuela De Medicina, Pontificia Universidad Católica De Chile, Santiago, Chile; Department of Medicine, Virginia Commonwealth University School of Medicine, Richmond, Virginia.
Zitieren
APA
Congly, S. E., Lee, B. P., Im, G. Y., Simonetto, D. A., Diaz, L. A., & Arab, J. P. (2026). Phosphatidylethanol Is Cost-effective to Accurately Detect Periodic Alcohol Use in Patients With Alcohol-associated Liver Disease. Clinical Gastroenterology and Hepatology, 24(2), 569-571. https://doi.org/10.1016/j.cgh.2025.07.022
Vancouver
Congly SE, Lee BP, Im GY, Simonetto DA, Diaz LA, Arab JP. Phosphatidylethanol Is Cost-effective to Accurately Detect Periodic Alcohol Use in Patients With Alcohol-associated Liver Disease. Clinical Gastroenterology and Hepatology. 2026;24(2):569-571. doi:10.1016/j.cgh.2025.07.022
BibTeX
@article{Congly2026,
author = {Congly, Stephen E and Lee, Brian P and Im, Gene Y and Simonetto, Douglas A and Diaz, Luis Antonio and Arab, Juan Pablo},
title = {Phosphatidylethanol Is Cost-effective to Accurately Detect Periodic Alcohol Use in Patients With Alcohol-associated Liver Disease},
journal = {Clinical Gastroenterology and Hepatology},
year = {2026},
volume = {24},
number = {2},
pages = {569--571},
doi = {10.1016/j.cgh.2025.07.022}
}
EUVIMED